92 related articles for article (PubMed ID: 3674760)
1. Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.
Misset JL; Metz R; Gil-Delgado M; Keiling R; Cappelaere P; Armand JP; Prévot G; Grimbert J; Mathé G; Hibberd M
Anticancer Res; 1987; 7(4B):737-40. PubMed ID: 3674760
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.
McDonald DB; Abu-Zahra H; Yoshida S; Binder H
Semin Oncol; 1984 Sep; 11(3 Suppl 1):19-22. PubMed ID: 6385260
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Momose F
Gan To Kagaku Ryoho; 1995 Jan; 22(1):83-6. PubMed ID: 7826082
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
Ehninger G; Weible KH; Heidemann EG; Waller HD
Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
[TBL] [Abstract][Full Text] [Related]
10. [Mitoxantrone containing multi-drug chemotherapy in the management of malignancies. Collaborative Group for Clinical Trial of Mitoxantrone].
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):300-3. PubMed ID: 2696630
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study.
Azim HA
J Infus Chemother; 1996; 6(2):102-6. PubMed ID: 8809659
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
Stewart DJ; Maroun JA; Hirte W; Perrault D; Stolbach L; Cripps C; Lefebvre B
Semin Oncol; 1984 Sep; 11(3 Suppl 1):23-7. PubMed ID: 6385261
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
Kosmidis PA; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
Chemioterapia; 1987 Dec; 6(6):393-5. PubMed ID: 3435921
[TBL] [Abstract][Full Text] [Related]
14. Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer.
Pavesi L; Preti P; Da Prada G; Pedrazzoli P; Poggi G; Robustelli della Cuna G
Anticancer Res; 1995; 15(2):495-501. PubMed ID: 7763029
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
Chen JA
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):202-4. PubMed ID: 8261866
[TBL] [Abstract][Full Text] [Related]
17. A clinical trial of mitoxantrone (novantrone) versus doxorubicin (adriamycin) in combination chemotherapy for metastatic breast cancer.
Büyükünal E; Derman U; Serdengecti S; Berkarda B
Chemioterapia; 1987 Oct; 6(5):377-9. PubMed ID: 3322590
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin, cyclophosphamide and vindesine (ACV) versus mitoxantrone, cyclophosphamide and vindesine (NCV) in advanced breast cancer.
Janssens JP; Chin Y; Deleu M; Bonte J; Staelens Y
Anticancer Res; 1993; 13(6B):2477-83. PubMed ID: 8135486
[TBL] [Abstract][Full Text] [Related]
20. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
